Private Harbour Investment Management & Counsel LLC raised its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 8.5% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 23,142 shares of the pharmacy operator’s stock after buying an additional 1,820 shares during the period. Walgreens Boots Alliance accounts for about 1.6% of Private Harbour Investment Management & Counsel LLC’s investment portfolio, making the stock its 23rd largest position. Private Harbour Investment Management & Counsel LLC’s holdings in Walgreens Boots Alliance were worth $1,922,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also modified their holdings of the company. Barings LLC boosted its position in shares of Walgreens Boots Alliance by 219.1% in the fourth quarter. Barings LLC now owns 28,602 shares of the pharmacy operator’s stock valued at $2,367,000 after buying an additional 19,639 shares in the last quarter. Pinnacle Financial Partners Inc. raised its stake in shares of Walgreens Boots Alliance by 30.5% in the fourth quarter. Pinnacle Financial Partners Inc. now owns 5,625 shares of the pharmacy operator’s stock worth $466,000 after buying an additional 1,315 shares during the last quarter. Empire Life Investments Inc. acquired a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth approximately $11,133,000. RB Capital Management LLC acquired a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth approximately $261,000. Finally, Lebenthal Asset Management LLC raised its stake in shares of Walgreens Boots Alliance by 0.5% in the fourth quarter. Lebenthal Asset Management LLC now owns 115,317 shares of the pharmacy operator’s stock worth $9,544,000 after buying an additional 629 shares during the last quarter. Institutional investors and hedge funds own 61.16% of the company’s stock.
Walgreens Boots Alliance, Inc. (NASDAQ WBA) traded down 1.06% on Friday, reaching $80.03. The company had a trading volume of 5,239,292 shares. Walgreens Boots Alliance, Inc. has a 1-year low of $75.18 and a 1-year high of $89.69. The stock has a market capitalization of $85.64 billion, a P/E ratio of 20.21 and a beta of 1.25. The stock’s 50 day moving average is $79.60 and its 200-day moving average is $82.28.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, beating the consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The company had revenue of $30.12 billion for the quarter, compared to analyst estimates of $29.72 billion. During the same period last year, the company earned $1.18 earnings per share. Walgreens Boots Alliance’s quarterly revenue was up 2.1% compared to the same quarter last year. On average, equities analysts predict that Walgreens Boots Alliance, Inc. will post $5.00 EPS for the current fiscal year.
Walgreens Boots Alliance declared that its Board of Directors has approved a share buyback program on Thursday, June 29th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to reacquire up to 5.9% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s board believes its stock is undervalued.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th will be issued a $0.40 dividend. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. This represents a $1.60 annualized dividend and a yield of 2.00%. The ex-dividend date of this dividend is Wednesday, August 16th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 40.30%.
Several brokerages have commented on WBA. Needham & Company LLC began coverage on Walgreens Boots Alliance in a research report on Tuesday, June 27th. They set a “hold” rating for the company. BidaskClub lowered Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Saturday, June 24th. Leerink Swann set a $86.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Friday, July 7th. Credit Suisse Group reissued a “buy” rating and set a $97.00 price objective on shares of Walgreens Boots Alliance in a research report on Thursday, July 13th. Finally, Pivotal Research set a $85.00 price objective on Walgreens Boots Alliance and gave the company a “hold” rating in a research report on Sunday, July 2nd. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and fourteen have issued a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $90.69.
In other news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction that occurred on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the transaction, the director now owns 19,151 shares in the company, valued at $1,528,058.29. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 13.50% of the stock is currently owned by company insiders.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.